CIK: 1511034 - Address: C/O Crispr Therapeutics, 105 West First Street, Boston, MA 02127
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1113-3-20-27-310-16
S%wins010010010010080

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/17/19 20:00
12/13/19
SRPTSarepta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMahatme SandeshMAOEVP,CFO,S.d-15,688125.500-125-7542D
2/8/19 20:02
2/7/19
SRPTSarepta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMahatme SandeshMAOEVP,CFO,S.d-9,425145.000-65-7621D
2/1/19 20:24
1/30/19
SRPTSarepta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMahatme SandeshMAOEVP,CFO,S.dm-8,465130.240-65-7621D
10/26/18 18:43
10/24/18
SRPTSarepta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMahatme SandeshMAOEVP,CFO,S.d-13,735127.740-108-8421M
7/21/17 21:49
7/20/17
SRPTSarepta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMahatme SandeshMAOEVP,CFO,S.d-2,05041.000-50-6034D
10/19/16 16:22
10/17/16
SRPTSarepta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMahatme SandeshMAOSVP,CFOS.d-1,50350.0833-30-4932D1248215312275-20-14-83-3-20-27-31

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact